Navigation Links
Repligen Announces Conference Call of First Quarter Fiscal Year 2009 Results
Date:7/31/2008

ade pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this release do not constitute guarantees of future performance. Investors are cautioned that statements in this press release which are not strictly historical statements, including, without limitation, statements regarding current or future financial performance and position, management's strategy, plans and objectives for future operations, plans and objectives for product development, plans and objectives for present and future clinical trials and results of such trials, plans and objectives for regulatory approval, litigation, intellectual property, product development, manufacturing plans and performance such as the anticipated growth in the monoclonal antibody market and our other target markets and projected growth in product sales, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including, without limitation, risks associated with: the success of current and future collaborative relationships, the market acceptance of our products, our ability to compete with larger, better financed pharmaceutical and biotechnology companies, new approaches to the treatment of our targeted diseases, our expectation of incurring continued losses, our uncertainty of product revenues and profits, our ability to generate future revenues, our ability to raise additional capital to continue our drug development programs, the success of our clinical trials, our ability to develop and commercialize products, our ability to obtain required regulatory approvals, our compliance with all Food and Drug Administration regulations, our ability to obtain, maintain and protect intellectual property rights for our products, the risk of litigati
'/>"/>
SOURCE Repligen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Repligen Reports Fourth Quarter and Fiscal Year 2008 Financial Results
2. Repligen Announces Settlement with Bristol-Myers Squibb in Orencia(R) Lawsuit
3. Repligen Announces Conference Call of Third Quarter Fiscal Year 2008 Results
4. Horizon Therapeutics Announces Corporate Relocation to the Chicago Area
5. Genta Announces Second Quarter 2008 Financial Results and Conference Call
6. Amicus Therapeutics Announces Second Quarter 2008 Results Release Date
7. PURE Bioscience Announces DuraBan International as Distributor of SDC-Based Disinfectant
8. Bioheart, Inc. Announces Financial Results for Second Quarter 2008
9. Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments
10. Bioheart, Inc. Announces Results of Annual Meeting
11. Geecf: Spectrum Blue Steel Announces Strategic Partnership with Al Manhal International Group of Abu Dhabi to Deploy Biosphere Facilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 While administrative claims and ... research for a relatively long period of time, ... the use of these ‘big data’ for comparisons ... combining today’s powerful computer technology with the plethora ... data’ holds significant promise for identifying optimal interventions ...
(Date:7/30/2014)... 2014   Wyle has been named ... Mission Support Services (FILMSS) contract awarded by the ... terms of the contract, Wyle will provide mission ... Calif. In particular, Wyle will provide program and ... on the International Space Station and collaborative science ...
(Date:7/30/2014)... BCC Research ( http://www.bccresearch.com ) reveals ... in Industrial Applications , the global market for industrial ... by 2018, registering a five-year compound annual growth rate ... recorded in the detergent enzyme segment with a CAGR ... has influenced almost every sector of industrial activity, ranging ...
(Date:7/30/2014)... DIEGO , July 30, 2014  Orexigen Therapeutics, ... has received the Day 180 List of Outstanding Issues ... Products for Human Use (CHMP) for the NB32 Marketing ... bupropion SR) is an investigational drug candidate being evaluated ... the earlier Day 120 time point were adequately addressed ...
Breaking Biology Technology:Leveraging ‘Big Data’ - Methodological Considerations in Health Services Research, New Webinar Hosted by Xtalks 2Wyle Wins NASA's Fully Integrated Lifecycle Mission Support Services Contract 2Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 2Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 3Orexigen Receives CHMP Day 180 List of Outstanding Issues 2Orexigen Receives CHMP Day 180 List of Outstanding Issues 3
... intensive research at the nanoscale is the creation of ... electrical throughput, low cost and easy processing, engineers foresee ... generations of touch-screens, video displays, light-emitting diodes and thin-film ... a major engineering hurdle: In processing, these delicate meshes ...
... 2012  The Angel Investor Management (AIM) Group announced today the ... the capital needs of entrepreneurs and investors in a seven-county ... bringing together a single network of angel investor groups in ... the economies of scale will work to benefit all," said ...
... Pa., Feb. 6, 2012  Auxilium Pharmaceuticals, Inc. (Nasdaq: ... today announced the appointment of two executive officers, ... Executive Vice President, Chief Administrative Officer and General ... Senior Vice President, Sales. "The leadership ...
Cached Biology Technology:Stanford engineers weld nanowires with light 2Statewide Network of Angel Investor Groups Announced in Alabama 2Auxilium Announces Appointments to Enhance Leadership Team 2Auxilium Announces Appointments to Enhance Leadership Team 3Auxilium Announces Appointments to Enhance Leadership Team 4Auxilium Announces Appointments to Enhance Leadership Team 5
(Date:7/31/2014)... Becquerel first discovered the photovoltaic effect in 1839, humankind ... of sunlight for its own purposes. In a new ... the FASEB Journal , scientists may ... of sunlight by focusing on a naturally occurring combination ... This conservationor persistence over time and across speciessuggests that ...
(Date:7/31/2014)... Fire was in full fury, raging swiftly from crown ... backcountry of Yosemite National Park in California,s Sierra Nevada ... battle began to turn, enacting a case study in ... fuel large, severe fires. , "When the Rim Fire ... had been used as a management tool, rather than ...
(Date:7/31/2014)... A Florida State University researcher found that bacteria ... toxic components of the oil released during the Deepwater ... not the most toxic contaminants. , In two new ... Olivia Mason found a species of bacteria called ... toluene, ethylbenzene and xylene compounds that were released as ...
Breaking Biology News(10 mins):Scientists shine bright new light on how living things capture energy from the sun 2The Rim Fire 1 year later: A natural experiment in fire ecology and management 2The Rim Fire 1 year later: A natural experiment in fire ecology and management 3The Rim Fire 1 year later: A natural experiment in fire ecology and management 4The Rim Fire 1 year later: A natural experiment in fire ecology and management 5
... how climate change might reshape our environment, they must ... For those considering the likely fate of particular ... thumb to help calculate the likely effect of climate ... the discussion about climate change focuses on the fate ...
... interaction for colorectal cancer was reported today (Thursday, Oct. ... meeting in Boston. The interaction may shed light on ... is associated with consumption of red and processed meat, ... a relevant public health significance because diet is a ...
... of scientists has identified an association between heritable, rare ... early onset breast cancer, according to research reported today ... 2013 annual meeting in Boston. The rare mutations ... three of 49 families participating in a study that ...
Cached Biology News:Climate change and coevolution: We've done the math 2Climate change and coevolution: We've done the math 3Gene-diet interaction may help explain link between eating meat & colorectal cancer risk 2Gene-diet interaction may help explain link between eating meat & colorectal cancer risk 3Mutations in novel tumor suppressor gene associated with early onset breast cancer 2
A trigger solution for Flashlight labeled materials....
... Lab Quantas unique combination of Coulter ... resolution capabilities and accurate cell counting. ... wavelengths, including UV, allowing flexible fluorochrome ... applications typically only achievable with larger, ...
... Reader is Cellomics‘ latest product ... Cell-based Screening". The KineticScan Reader ... do both temporal and high-resolution ... dynamic distribution and activity of ...
... cytometry system is the superior cell-sorting instrument ... years, BD cell sorters have been the ... university, pharmaceutical, and biotechnology research facilities throughout ... demands of today, we have improved the ...
Biology Products: